Skip to main content
. Author manuscript; available in PMC: 2009 Mar 19.
Published in final edited form as: J Comp Neurol. 2008 Apr 20;507(6):1879–1900. doi: 10.1002/cne.21611

TABLE 1.

Summary of Experiments

Experiment1 Case CTβG/WAHG2 CTβ Survival (days) Figure
1 1436 AAF2 AI 4
2 1439 AI2 AI 3
3 1443 AI2 AII 4 4
4 1444 AII2 AII 4
5 1447 ED2 EI 5
6 1469 ED EI 4
7 1488 EI AII 3
8 1499 Te Te 3 10
9 1501 AII Te 3
10 1522 In In 3
11 1524 In In 4
12 1527 EV VP 3 9
13 1537 AAF DZ 3 5
14 1549 P VP 3 6
15 1553 AES ED 2 7
16 1555 Te EV 3
17 1560 In ED 3 8
18 1569 AES AES 3
19 1579 AES DZ 3
20 1601 Ve VP 3 3
21 1602 PFC PFC 3
223 1561 AAF AI 3
233 1568 AAF AI 3
243 1572 AAF AI 3
253 1599 AAF AI 3
1

Experiment numbers in Figure 1.

2

WAHG injections.

3

Physiologically-mapped deposit.